FEATURED NEWS
- September 16, 2026Health
Protheragen Launches Specialized Pharmacokinetic Service Platform for Anti-Obesity Therapeutics
Protheragen , a contract research organization (CRO) focused on preclinical drug development services, has launched a service offering focused on preclinical in vivo and in vitro pharmacokinetic (PK) evaluation of anti-obesity therapeutic drugs. According to the WHO, more than one billion people worldwide are living with obesity, creating an urgent need for safe and effective new therapeutic drugs. The integrated service offering provides biotech and pharma partners with key ADME data to reduce risk and accelerate development of next-generation anti-obesity therapeutics. Protheragen's anti-obesity therapeutic PK study offering is a specialized service, compared to conventional PK evaluations, that takes into account the fundamental changes that the state of obesity imposes on human physiology (i.e. changes in gastric emptying, metabolic organ perfusion, and metabolic rate). As a result of these changes, the behavior of drugs in the body is also altered, making conventional PK assessments insufficient. The integrated, one-stop research program undertaken by Protheragen is designed to understand drug behavior and address challenges associated with drug fate and elimination. Protheragen's integrated service offering includes in-depth evaluation of candidate drugs for anti-obesity therapeutics in terms of absorption, distribution, metabolism, and excretion. This includes assessment of absorption and bioavailability, concentration of the drug in different tissues with evaluation of the organ blood flow and binding of the drug with plasma proteins. Protheragen employs high-performance liquid chromatography (HPLC), thin layer chromatography (TLC), capillary electrophoresis (CE), and mass spectrometry (MS) to identify metabolites of drugs and their pathways. The company also constructs validated obesity models —spanning cell-based systems and animal models such as mice, rats, rabbits, and beagles—ensuring PK data is generated in biologically relevant systems. Beyond PK analysis, Protheragen offers comprehensive services for therapeutic modalities that include small molecules, gene therapies, cell therapies, antibody therapies, tissue engineering, and nanotherapies. Within small molecule therapies, Protheragen performs natural products and compound screens on the melanocortin-4 receptor (MC4R), leptin receptor (LepR), and adiponectin receptor (AdipoR) pathways. For advanced biologics, Protheragen employs gene editing to design tailored gene therapies, uses phage display and hybridoma technologies for antibody design, and evaluates nanotechnology for weight loss. Protheragen can assist partners from target identification to IND-enabling. The purpose of the Protheragen Pharmacokinetic Study of Anti-Obesity Therapeutics is to characterize the pharmacokinetic profile and exposure-response relationships of drug candidates, determine optimal dosing regimens, and identify potential drug-drug interactions—data that inform subsequent safety, efficacy, and combination therapy design. Protheragen has the experience to perform the studies and provide comprehensive reports to support clients in making informed decisions. As obesity research evolves toward precision medicine, Protheragen remains committed to providing the scientific foundation for safer, more effective therapies. About Protheragen Protheragen is a premier CRO dedicated to accelerating drug discovery through innovative preclinical solutions. With state-of-the-art laboratories and expert scientists, the company provides services spanning disease modeling, PK/PD evaluation, safety assessment, and bioanalysis. Protheragen specializes in obesity, oncology, and metabolic disorders, empowering partners to transform discoveries into life-changing medicines.
- September 16, 2026Technology
Automation Testing Market Gains Momentum at 14.64% CAGR as AI and DevOps Redefine Software Quality
Industry Research Biz has released its latest analysis of the global Automation Testing Market, projecting growth from USD 44,669.89 million in 2026 to USD 152,797.38 million by 2035, representing a compound annual growth rate (CAGR) of 14.64%. The research attributes this growth to accelerating DevOps adoption, shorter software release cycles, expanding cloud application development, and rising enterprise investment in AI-assisted quality engineering. For detailed segmentation, regional breakdowns, and competitive analysis, visit @ https://www.industryresearch.biz/market-reports/automation-testing-market-103372 Why Automation Testing Is Becoming Essential Infrastructure for Modern Software Development There was a time when software testing largely happened after developers had finished building an application. A product moved from development to a dedicated quality-assurance team, defects were identified, fixes were made, and the release eventually reached customers. That model becomes difficult to maintain when software changes several times in a single day. Modern development teams increasingly operate through continuous integration and continuous delivery environments, where code is created, tested and deployed in increasingly short cycles. Approximately 67% of digitally mature organizations are expanding automated testing coverage because manual validation alone cannot keep pace with the frequency and complexity of modern software releases. That is turning automation testing from a productivity tool into a fundamental part of software development infrastructure. The Release Cycle Changed — and Testing Had to Change With It The shift toward DevOps has changed where testing happens in the development lifecycle. Rather than waiting until a product is almost ready for release, approximately 61% of organizations operating mature DevOps environments now execute automated validation at multiple development stages. Testing can begin as soon as developers modify code. Automated regression, API, browser and integration tests can run continuously, allowing defects to be identified before they spread into production environments. This becomes especially important as applications increasingly operate across cloud infrastructure, mobile devices, browsers, databases and external services at the same time. Generative AI is adding another layer of pressure. Approximately 61% of quality engineering teams are experiencing increased testing requirements as developers generate and modify code more rapidly. Faster software creation means more workflows, configurations and edge cases must be validated before release. AI Is Starting to Rewrite Automation Testing Itself Traditional automation frameworks rely heavily on predefined scripts. Those scripts work efficiently until an application interface, workflow or supporting system changes. Approximately 30% of automation initiatives experience delays or reduced effectiveness because unstable scripts, fragmented tools, legacy applications and integration complexity create ongoing maintenance requirements. AI-assisted testing is beginning to change that model. Approximately 39% of advanced automation environments now incorporate intelligent capabilities such as natural-language test generation, self-healing selectors, automated test prioritization and AI-assisted root-cause analysis. Instead of simply executing fixed instructions, newer testing systems can identify application changes and automatically adjust parts of the testing process. Approximately 54% of enterprise quality teams are now evaluating technologies capable of automatically generating, executing and maintaining test scenarios with reduced human intervention. Web Testing Leads, but Mobile and Desktop Remain Critical The type-based market breakdown shows how testing demand is distributed across modern software environments. Web testing represents approximately 44% of market demand, making it the largest segment. Browser-based enterprise applications, cloud software, customer portals and e-commerce systems require continuous validation across multiple browsers, operating systems and screen configurations. Mobile testing contributes approximately 33%. Around 58% of enterprise mobile applications require validation across multiple operating-system versions and device profiles, strengthening demand for automated device testing, emulators, visual validation and cloud-based testing environments. Desktop testing accounts for the remaining 23%. Although desktop software receives less attention than web and mobile platforms, it continues to support critical operations across manufacturing, engineering, financial services, utilities and defense. Together, Web at 44%, Mobile at 33% and Desktop at 23% represent 100% of type-based market demand. Where Application Demand Is Concentrated Telecom and IT represents the largest application segment at approximately 23% of market demand. Around 76% of mature Telecom and IT development teams already use automated testing within continuous integration workflows as cloud services, network applications and enterprise platforms require frequent software updates. Banking, Financial Services and Insurance accounts for approximately 17%, supported by digital banking, payment processing and regulatory applications. Retail represents 12%, Automotive contributes 11%, and Healthcare and Life Sciences accounts for around 10%. Defense and Aerospace represents approximately 8%, Manufacturing contributes 7%, while Logistics and Transportation and Energy and Utilities each account for 6%. The complete application distribution therefore totals 100%, reflecting the growing role of automated quality assurance across nearly every software-intensive industry. The Hardest Problem May Be Maintaining the Automation Creating automated tests is only part of the challenge. Approximately 35% of organizations report difficulty finding professionals with expertise across software development, testing frameworks, DevOps and quality engineering. Large automation programs require teams capable of maintaining test architecture, managing environments and integrating execution into increasingly complicated development pipelines. Application complexity is also increasing. Approximately 46% of enterprise applications depend on multiple external components or microservices, meaning one customer transaction may involve authentication services, APIs, databases, payment infrastructure and third-party providers. Testing data adds another difficulty. Approximately 40% of complex testing programs require synthetic, masked or specially prepared datasets because sensitive production information cannot always be copied safely into development environments. These challenges are strengthening demand for cloud testing, test-data management, service virtualization and intelligent maintenance tools. Testing AI Applications Is Becoming a Market Opportunity of Its Own The growth of AI-enabled software is creating an entirely new testing requirement. Approximately 48% of enterprise software modernization initiatives now involve AI-assisted or AI-integrated functionality. Unlike conventional software, AI applications may generate probabilistic or context-dependent outputs that cannot always be evaluated through simple pass-or-fail rules. Organizations increasingly need automated methods for evaluating model behavior, generated responses, data quality and autonomous agent actions. That creates a significant opportunity for testing platforms capable of validating AI-driven applications across banking, healthcare, aerospace, enterprise technology and other environments where software errors can create substantial operational consequences. North America Leads, While Asia-Pacific Expands Rapidly North America represents approximately 38% of global Automation Testing Market demand, making it the largest regional market. Mature DevOps adoption, extensive enterprise software development and early use of AI-assisted testing platforms continue to support regional leadership. Approximately 71% of digitally advanced North American enterprises already use automated testing across more than one application environment. Asia-Pacific accounts for approximately 27% of market demand, supported by rapid digital transformation across India, China, Japan, South Korea, Australia and Southeast Asia. Competition Is Moving Toward Intelligent Testing Platforms Competition is increasingly shifting toward AI-assisted and consolidated testing environments. Approximately 27% of competitive product initiatives now emphasize generative AI, autonomous testing agents, low-code automation, self-healing functionality or unified quality engineering platforms. Major participants include IBM, SmartBear Software, TestPlant, Cognizant Technology, CA Technologies, Micro Focus, Hewlett-Packard, Wipro Ltd., Capgemini, Ranorex, Parasoft and Cigniti Technologies. Approximately 52% of enterprise buyers increasingly prefer platforms that reduce dependence on multiple disconnected testing tools, encouraging vendors to combine web, mobile, desktop, API, functional and regression testing within more unified environments. That shift points toward a broader change in software quality engineering: automation testing is moving from scripts that simply execute predefined actions toward intelligent systems capable of generating tests, adapting to application changes and operating continuously throughout the development lifecycle. Download Free Sample PDF @ https://www.industryresearch.biz/enquiry/request-sample/Automation-Testing-Market-103372
- September 16, 2026Apps & Software
TermSquad Launches an Always-On Cloud Computer for AI Coding Agents
Persistent sessions, shared project memory and multi-agent orchestration let developers continue work across devices without keeping a laptop open. TermSquad has launched a managed cloud computer for AI coding agents, bringing persistent sessions, shared memory and multi-agent orchestration into one Linux environment. Developers can leave agents running when they close their laptop and reconnect from a desktop browser, phone or compatible SSH tool. TermSquad provides the computer, while developers choose their agents and models. Repositories, files and configurations stay in the remote environment rather than depending on a local device. Keep agent sessions running across devices TermSquad supports Codex, Claude Code, OpenCode, Cursor, GitHub Copilot and other coding tools. Users install their chosen agents from the dashboard and connect existing accounts, subscriptions or API keys as supported by each tool. The platform uses Herdr to manage persistent sessions, workspaces and terminal panes. Closing the browser does not end those sessions. Users can return through the mobile-friendly web terminal or compatible desktop development tools over SSH. Coordinate implementation, review and debate with Squad Squad is TermSquad’s multi-agent orchestration capability. Within Herdr-managed sessions, a lead agent can assign implementation and review to other agents, run independent tasks in parallel and collect their results. Users can choose different agents and models for each role. Squad also includes Debate: two agents develop independent proposals and challenge each other’s reasoning over successive rounds. The result records explicit agreement or a lack of consensus, with a local transcript available for review. Share project knowledge with Squad Memory Squad Memory stores selected project knowledge, including architectural decisions, coding conventions and session summaries. Compatible agents on the same computer can retrieve that knowledge in later sessions, with memories organized by project. For example, a decision saved while working with Claude Code can later be retrieved by Codex on that computer. Persistent sessions preserve the working session; Squad Memory preserves selected knowledge. Its store stays on the user’s TermSquad computer. Manage the computer and its workloads Beyond agent coordination, TermSquad includes browser-based file management and editing, GitHub connection, an overview of agent states and resource monitoring. TermSquad Guard adds protection designed to reduce the risk of runaway agent workloads overwhelming the machine. Users can manage multiple computers from one account. TermSquad manages machine setup and core platform maintenance while users retain control of their projects, tools and files. About TermSquad TermSquad provides persistent, managed Linux computers for developers and founders working with AI agents. The platform combines browser and SSH access, multi-agent orchestration and shared project memory in an environment users can access across devices. Additional information about TermSquad, including product details, supported AI coding agents and platform capabilities, is available at https://termsquad.com . Product updates and announcements are published at https://x.com/trytermsquad .
- September 16, 2026Health
Signature Clinic announces new surgeon appointments as UK team continues to grow
Signature Clinic , one of the UK’s largest cosmetic surgery providers, has announced the appointment of two new surgeons as the organisation continues to strengthen its clinical team and expand the range of expertise available to patients across its growing network of clinics. The appointments of Dr Huseyin Can Yucel and Dr Bikram Jit Singh bring significant additional experience across cosmetic, reconstructive, facial, breast and body contouring surgery. Together, the surgeons bring decades of international surgical experience, with training and clinical work spanning the UK, Europe, the United States, India and Turkey. Dr Sayani Sainudeen, Founder of Signature Clinic said: “We are delighted to welcome Huseyin and Bikram to Signature Clinic. As we continue to grow, it is incredibly important that we bring talented, experienced surgeons into the organisation who share our commitment to patient care, clinical standards and considered surgical outcomes. Each of these surgeons brings a different breadth of experience and specialist expertise to Signature Clinic, from reconstructive microsurgery and complex facial procedures through to breast surgery, body contouring and aesthetic surgery. The strength and depth of our surgical team is central to the service we provide to patients and these appointments represent another important step in the continued development of Signature Clinic.” Dr Huseyin Can Yucel trained at Istanbul University, Istanbul Faculty of Medicine, completing five and a half years of residency training in one of Turkey’s leading academic surgical departments. He holds Membership of the Royal College of Surgeons of England and is a Fellow of the European Board of Plastic, Reconstructive and Aesthetic Surgery. He is also registered with the General Medical Council with a licence to practise in the UK. His training spans reconstructive microsurgery, craniofacial surgery, breast surgery and body contouring, giving him experience across both functional and aesthetic plastic surgery. His practice includes facelift, neck lift, brow lift, blepharoplasty, rhinoplasty, breast augmentation, breast lift, breast reduction, liposuction, abdominoplasty and post-weight-loss body contouring. Alongside his clinical work, Dr Yucel remains active in surgical research, with peer-reviewed publications in internationally recognised journals. Dr Bikram Jit Singh joins Signature Clinic with more than 15 years of international surgical experience across India, Switzerland, Sweden, the United States and the United Kingdom. He completed his MBBS, MS in General Surgery and MCh in Burns and Plastic Surgery at Pt. B. D. Sharma University of Health Sciences in Rohtak and subsequently completed his MRCS in Edinburgh. His international training has included a fellowship in Plastic and Hand Surgery at the University of Bern, Inselspital in Switzerland, an ISAPS Fellowship in California and a fellowship at Akademikliniken in Stockholm. He has also held consultant positions in India and currently works within the NHS surgical pathway as an ST6 Registrar at Countess of Chester Hospital. At Signature Clinic, Dr Singh performs a wide range of cosmetic procedures including upper blepharoplasty, otoplasty, liposuction, abdominoplasty, arm lift, gynaecomastia surgery, labiaplasty and vaginoplasty. He is fluent in English, Hindi and Punjabi. The new appointments form part of Signature Clinic’s continued investment in clinical expertise as the organisation grows its presence across the UK and Ireland. Signature Clinic provides a wide range of surgical and non-surgical treatments including facelifts, blepharoplasty, gynaecomastia surgery, body contouring procedures, labiaplasty, injectables and advanced skin treatments. Its clinics operate seven days a week, giving patients access to a broad range of appointment and treatment options. Signature Clinic is a pioneer in day-case procedures under local anaesthetic, with care delivered by GMC-registered surgeons. Its clinics are regulated by the relevant healthcare regulators including CQC, HIW and HIS, with ongoing follow-up care and patient support forming part of its treatment pathway.
- September 16, 2026Others
Voghion Launches Trends, a Content Community Connecting Discovery, Entertainment and Shopping
Voghion , a London-based online marketplace, announced the launch of Trends , a new content community within its app that brings together product discovery, user-generated content, creator sharing, short-form video and entertainment. The launch adds a new dimension to Voghion's shopping experience, bringing products into a broader content environment where people can discover inspiration, see how others live and shop, and explore things they may not have been actively searching for. A More Natural Way to Discover Products Shopping discovery does not always begin with a search. A product can catch someone's attention through an outfit, a recommendation, a personal experience, a video or simply something another person has shared. Voghion's new content community is designed around this more open-ended way of discovering products. Its content feed uses users' interests and interactions to recommend relevant photos and videos, allowing different users to encounter different ideas and products as they browse. The experience gives products more context by placing them alongside the people, experiences and creative ideas behind them. A fashion item can appear as part of someone's outfit, a home product can be seen in a real living space, or a beauty product can become part of someone's daily routine. This creates a shopping experience that is less about simply searching for a product and more about discovering something that feels relevant to the individual user. A Community Shaped by Its Users and Creators At the heart of Trends is content shared by the community itself. Users can share their purchases, personal styles, daily experiences and creative ideas through photos and videos, while creators and KOLs can share recommendations, inspiration and their own perspectives on products and trends. This user- and creator-generated content gives shoppers a view of products beyond standard product listings. Instead of seeing only product photography and descriptions, they can see how other people actually use, wear or experience the things they buy. For those sharing content, the community also provides a space to express personal interests and creativity. For those browsing, it creates an opportunity to discover new ideas through the experiences and perspectives of other members of the community. Over time, this creates a more diverse picture of the interests and lifestyles represented on Voghion — shaped by what people choose to share rather than by products alone. From Product Discovery to Entertainment The content community also goes beyond shopping-related content, bringing short-form video and short drama into the same experience. Users can browse quick, visually driven videos covering a range of interests, creative ideas and everyday moments, while short-form dramas add a more entertainment-focused dimension to the experience. This means users do not necessarily need to arrive with a specific shopping intention. They can browse because they want inspiration, follow content that interests them, watch something entertaining or see what other people are sharing — and discover products along the way. By bringing these different types of content together, the community connects product discovery with the broader ways people already spend time online. Bringing Shopping and Lifestyle Closer Together Voghion has traditionally connected customers with more than 300 product categories, spanning fashion, beauty, electronics, home, lifestyle and more. The new content community adds a layer of community and content to that marketplace, giving products a place within the everyday stories, interests and creativity of its users. The result is an experience where shopping is not isolated from the rest of people's digital lives. A customer might discover a product through another user's post, find inspiration from a creator, watch a short video or become interested in something simply because it appears in content they enjoy. In this way, Trends makes Voghion more than a destination for purchasing products. It creates a more three-dimensional representation of people's lifestyles, bringing together what they shop for, what they like, what they share and what they find interesting. As Trends develops, Voghion aims to continue growing its content community and creating more opportunities for users and creators to share, discover and explore within the shopping experience. About Voghion Founded in 2021, Voghion is a London-based online marketplace serving customers across the UK, Europe, and over 40 countries worldwide. Backed by a global supply chain, it offers a wide range of quality products across fashion, home, beauty, electronics, lifestyle, and specialty categories. For more information about Voghion, use the contact details below.
- September 16, 2026Marketing
Directories supply 41% of AI citations on supplier-selection prompts, new GEO and AEO study finds
London, 15 September 2026. Sector directories accounted for 41% of the citations behind AI-generated provider recommendations, against 18% for brand-owned pages, according to a study published today by Citations.press. The research, Sector Directories Are Driving AI Overview Citations , analysed 3,850 commercial prompts across ChatGPT, Google AI Mode, Perplexity and Google AI Overviews between 10 June and 22 August 2026. The study reports that brand homepages appeared in 14% of all responses and in 6% of responses to prompts that named a category rather than a company. In the engineering category, directory citations exceeded brand-site citations by 4.2 to 1. What the study reports Directories supplied 41% of citations on supplier-selection prompts, against 18% for brand-owned pages. 68% of directory citations came from list pages rather than individual profile pages. Directories with one entity per entry and consistent attributes were cited 3.1 times more often than directories with free-text listings. Citation rates for sector directories on category prompts were 47% on Perplexity, 39% on Google AI Overviews, 36% on Google AI Mode and 22% on ChatGPT. Overlap between the cited source sets across the four platforms was 31%. Variation between sectors The gap between directory and brand-site citations was not uniform. It was widest in engineering, where the sample was drawn from listings on Engineering Panel , at 4.2 directory citations for every brand-site citation. The IT supplier category, sampled from IT Suppliers , and the channel partner category, sampled from Partner Base , both showed the procurement-style prompt pattern the study associates with high directory citation rates. Agency selection, sampled from Agency Roster , and training provider selection, sampled from Trainers List , produced the highest volume of category prompts in the set. The consumer category, sampled from Secret Salons , was the only one in which assistants returned named individual businesses more often than provider lists. All figures above are first-party measurements produced by Citations.press. They have not been replicated by an independent party. The underlying records are published so that others can attempt replication. Correlation with domain authority Within this dataset, the study found a weak relationship between a directory’s domain authority and how often it was cited, reported as a Spearman rank correlation of 0.19. Coverage depth within a stated category was the stronger predictor. The study notes that a correlation of this size across a single dataset indicates an association rather than a causal relationship, and that the result may not hold in categories outside those tested. “A model answering a narrow category question appears to favour a source that resolves that question completely over a source that is generally trusted. That is what our data points to. It is one dataset, over one summer, in a handful of sectors, and it needs replicating.” How the findings sit against published research Three larger studies published over the past year report broadly compatible patterns. Each is listed at the end of this release. DeltaV Digital examined 25,337 citations across 21,075 AI engine responses covering eight brands over 90 days, and reported that listicles accounted for 19.6% of citations across its portfolio and 61% within B2B technology services, where own-domain citation share was recorded as 0%. Its authors concluded that "AI visibility is won on other people’s websites." Semrush analysed more than 100 million citations across 230,000 prompts on ChatGPT Search, Google AI Mode and Perplexity over thirteen weeks, and reported citation weight concentrated among a small number of aggregating platforms. Peec AI reviewed 30 million cited sources across five AI search surfaces and reported that listing and review platforms including G2 and Yelp appeared frequently in recommendation queries. These studies measure different samples over different periods and were not designed to test the question examined here. They are offered as context, not as corroboration of the figures reported above. Methodology 3,850 prompts were run across ChatGPT, Google AI Mode, Perplexity and Google AI Overviews between 10 June and 22 August 2026. Prompts were divided into category prompts, which named a sector but no company (2,140 prompts, 56% of the set), comparison prompts (890, 23%) and verification prompts, which named a specific company (820, 21%). For each response, every cited URL was recorded and the source domain classified by type. Classification was carried out manually for the first 400 responses and by rule thereafter. A 200-response sample was re-checked by hand, showing 94% agreement with the rule-based classification. The directory test set comprised six vertical directories, one for each sector examined: engineering, IT supply, channel partnerships, agency selection, training provision and independent consumer services. Directory citation rates for every other domain in the dataset were measured using the same method. Stated limitations include response instability across repeated runs, accounts and regions, a prompt set weighted towards the sectors tested, judgement involved in source-type classification, and the fact that citation frequency was measured rather than any effect on purchasing behaviour. Materials available to editors The following are published in full alongside the study and are available to any editor or researcher on request: the complete 3,850-prompt set, raw citation records for every response, the source-type classification rules, the 200-response manual audit used to derive the 94% agreement figure, and the platform-level breakdown behind the citation rates quoted above. Referenced research DeltaV Digital, AI Citation Study, 2026. Semrush, The Most-Cited Domains in AI: A Three-Month Study. Peec AI, Top Domains Cited by AI Search, as reported by Search Engine Land. About Citations.press Citations.press publishes research on how AI assistants select, cite and attribute sources, and operates the sector directories used as the study’s test set. Full methodology and raw citation records are published with the study.
- September 16, 2026Others
James Champion Honored with USTA President's 35x35 Impact Award
James A. Champion has been named a recipient of the USTA President's 35x35 Impact Award, a national honor recognizing individuals who have made a significant contribution to growing tennis and helping the United States Tennis Association reach its goal of 35 million players by 2035. The award was presented by Brian Vahaly, President and Chairman of the Board of the USTA, and Paul Farah, Chair of the USTA Awards and Recognition Committee. "It is my honor to receive this award because the game of tennis means so much to me. For the organization that I help run, First Serve Miami, we use tennis to help underserved communities achieve life goals. Tennis, along with life skills and other educational enrichment programs teaches them to perform on and off the court. For us, tennis, It’s All About The Kids," said Champion. The 35x35 Impact Award highlights individuals across the country whose efforts, whether through coaching, community programs, advocacy, or player development, are helping expand access to tennis and strengthen the sport's future. Champion serves as Chairman of the Board of First Serve Miami , a nonprofit that has spent more than 40 years empowering underserved youth in Miami-Dade County through tennis, life-skills, and other educational enrichment programs. Under his leadership, First Serve Miami currently reaches over 400 participants per month through its Adopt-A-Player and Community Partners programs, operating out of the Ashe-Buchholz Tennis Center at Moore Park and other community parks and organizations such as Bryan Park, AJ King Park, Buccaneer Park, Bunche Park, Demps Park, Mary Saunders Park, Norwood Park, River Run Park, Sgt. Delancey Park, Walter Frazier Park, The Barnyard, Sunshine Hearts, MDSO Youth Outreach Unit, and local area public schools. For more information about First Serve Miami use the contact details below.
- September 16, 2026Education
Rider University Receives Grant for Vocational College Education as Career Planning Expands Beyond Job Placement
College students face decisions that extend beyond choosing a major or first job. Many are also considering what kind of work fits their interests and values. Rider University is addressing that question through a new vocational exploration initiative. Rider recently received a 2026 Professional Development Award from the Council of Independent Colleges. The award comes through its Network for Vocation in Undergraduate Education, known as NetVUE. Rider is one of 46 institutions selected for the award this year. The grant will support a new campus initiative focused on vocation and self-understanding. Rider plans six workshops designed specifically for students. Four additional workshops will prepare faculty and staff to support vocational exploration across the university. The workshops will also create a common framework for discussing vocation on campus. Students can approach those conversations from different majors. Faculty and staff gain tools for supporting the process. The work will culminate in a new Certificate in Vocation and Self-Understanding. The certificate is designed to prepare participants to help other people explore their calling. Rider describes vocation as a concept that reaches beyond simply finding employment. That approach gives the initiative a different role within college education. Traditional career preparation often centers on résumés, interviews, internships, and job searches. Vocational exploration asks students to examine why particular work may be meaningful to them. Darryl Mace, Rider's vice president of community engagement and belonging, connected calling with purpose and resilience. He said the program should help community members find careers they are passionate about. The workshops create a structured setting for that process. Rider's project also extends the work beyond students. Faculty and staff workshops will build their knowledge and capacity around vocational exploration. Participants can then apply those concepts when supporting students as they consider academic and professional decisions. The initiative arrives within a national network devoted to this area of higher education. NetVUE includes nearly 350 colleges and universities. The network supports vocational exploration and discernment among undergraduate students. It is a program of the Council of Independent Colleges. For a student, vocational exploration can add another layer to career planning. Someone may know which subjects they enjoy but remain unsure about their professional direction. Guided reflection can help connect academic interests with values, strengths, and possible forms of work. The project complements Rider's broad academic structure. The university offers programs across business, humanities, sciences, education, technology, media, and the arts. Its 2026-27 catalog includes undergraduate majors, minors, certificates, and concentrations across its colleges and schools. Rider's new initiative focuses on helping people examine the purpose behind those academic choices. The planned certificate also creates a pathway for participants to guide others through similar questions. Together, the workshops and credential bring vocational exploration into a defined educational program.
- September 16, 2026Business
WARCO Hosts House Member Rep. Correa at Southern California Factory to Discuss Growth, Jobs, Taxes
In a recent “in-district” event, Rep. Lou Correa (D-CA) met with the workers and leadership at rubber manufacturer West American Rubber Company (WARCO), based here, to learn about the challenges family-owned businesses face, business growth, and taxation. Rep. Correa toured WARCO facilities with Timothy Hemstreet , Chief Executive Officer, WARCO, a 115-year-old rubber manufacturing business and an industry leader in California made sheet, molded, and extruded rubber products. The family-owned business manages the process from research and development to raw material procurement, to mixing, to production, and to final packaged finished products. Rep. Correa, Co-Chair of the Congressional Family Business Caucus, met with and spoke to Hemstreet and WARCO workers on the issues of healthcare, business growth, and social security. “It was great exciting having Rep. Correa come to our facility to meet our exceptional people, see how we work, understand our challenges, and get a better understanding of the policies we need to help our community together,” said WARCO’s Hemstreet. Rep. Correa discussed a variety of legislative topics, including potential progress in healthcare legislation, the need to address the long-term needs of Social Security, and the importance of hard-working family businesses in communities. The event was organized by Family Enterprise USA, Washington, D.C., advocates for family-owned businesses across the country. In attendance were Tim Schultz, Chief Executive Officer, and Pat Soldano, President, of Family Enterprise USA and its sister organization, Family Enterprise USA Action. WARCO, with 180 employees, is a member of Family Enterprise USA, and the event is part of series of meetings between family-owned businesses and their district Congressional lawmakers organized by Family Enterprise USA. “It’s important that we in Congress understand the day to day needs of family businesses in our districts,” said Rep. Correa at the WARCO event. “Family businesses are the engine that keeps this country moving forward, and we must understand how important family businesses are to growing the economy, creating jobs, being responsible to their employees, and to our communities,” he said. Since 2017, Rep. Correa has represented California’s 46th congressional district, serving Orange County’s majority Hispanic area, including the cities of Anaheim, Santa Ana, and Orange. “Our role is to be a ‘hub,’ or connector, of family-owned businesses with our legislators,” said Schultz of Family Enterprise USA. “Connecting Congressman Correa directly with leading families of family businesses in his district is part of educating our lawmakers on the challenges family-owned businesses face every day,” he said. “Knowing these real-life challenges will help lawmakers make better policies to grow the economy, support employees, and build communities.” America’s family businesses are the largest private employers in the country, accounting for 83.3 million jobs in some 32 million family businesses across the country, according to research. These businesses contribute $7.7 trillion annually to U.S. gross domestic product. For more information go to: Family Enterprise USA About FAMILY ENTERPRISE USA Family Enterprise USA promotes family-owned business creation, growth, viability, and sustainability by advocating for family businesses and their lifetime of savings with Congress in Washington, D.C. FEUSA represents and celebrates all sizes, professions and industries of family-owned enterprises and multi-generational employers. FEUSA is a 501.C3 organization. About FAMILY ENTERPRISE USA ACTION Family Enterprise USA Action (formerly Policy and Taxation Group) engages with legislators on Capitol Hill on behalf of family-owned businesses, family offices, and successful families. It is focused exclusively on the critical tax and economic policies that impact them. FEUSA Action is the leading advocacy group working daily in Washington, D.C., to reduce and eliminate estate tax, gift tax, and generation skipping transfer tax while blocking increased income and capital gains taxes, the creation of a wealth tax, and other hostile policies that punish hardworking taxpayers and success in the U.S. It is a bipartisan 501.c4 organization.
- September 16, 2026Science
Global Times: CNNC, IAEA sign HTGR cooperation agreement to share China’s advanced nuclear experience with intl community
Photo: official WeChat account of China National Nuclear Corporation (CNNC) According to a report in the Global Times, China National Nuclear Corporation (CNNC) and the International Atomic Energy Agency (IAEA) have signed a cooperation agreement in the field of high-temperature gas-cooled reactors (HTGRs), paving the way for broader international sharing of China’s engineering experience in advanced nuclear technology, according to CNNC. The agreement was signed by Chinergy Co Ltd, a subsidiary of CNNC, and the IAEA on Monday local time, as the IAEA’s 70th General Conference opened in Vienna. A Chinese exhibition themed around small modular reactors and the integrated use of nuclear energy also opened on the same day. IAEA Director General Rafael Mariano Grossi, China Atomic Energy Authority (CAEA) director Shan Zhongde, China’s Permanent Representative to the IAEA, Ambassador Li Song, and CNNC General Manager Zhang Tao were among those who visited the exhibition and witnessed the signing. Grossi was briefed on China’s innovative nuclear energy solutions, including HTGRs and Linglong One, which is also known as ACP 100, as well as their applications. He also followed the progress of China’s small modular reactor (SMR) projects and spoke highly of CNNC’s contribution to innovative SMR applications, according to CNNC. The exhibition showcased China’s advances in nuclear technologies and efforts to expand the integrated use of nuclear energy. Under the cooperation agreement, Chinergy and the IAEA will conduct exchanges and cooperation in areas including the research and development, design, construction, commissioning and operation of HTGR nuclear power plants, as well as supply chains and personnel training, according to CNNC. CNNC said the cooperation will enable countries around the world to share China’s practical experience in HTGR engineering and further promote the use of the technology globally in low-carbon applications including power generation, industrial heat supply and hydrogen production. As the global energy transition continues, addressing climate change, strengthening energy security and advancing green and low-carbon development have become common goals worldwide. A growing number of countries have also endorsed the Declaration to Triple Nuclear Energy, while exploring new approaches to the peaceful use of nuclear energy. CNNC has long been advancing the development and engineering application of advanced nuclear technologies, including SMRs and advanced fourth-generation reactors, seeking to provide comprehensive coverage of nuclear energy options for different application scenarios and energy needs. The company has also been advancing the integration of nuclear energy with the petrochemical industry, combining nuclear energy’s clean-energy advantages with the high heat demand of petrochemical production as a way to support the low-carbon transformation of energy-intensive industries. HTGR technology, an advanced reactor technology with fourth-generation nuclear technology features, has broad potential in areas including industrial heat supply and integrated energy use, according to CNNC. Construction of the Xuwei Nuclear Heating and Power Plant in East China’s Jiangsu Province officially began on January 16, 2026. It is the world’s first nuclear plant to couple high-temperature gas-cooled reactor technology with pressurized water reactors while focusing primarily on industrial heat supply and providing electricity as a supplement. The project marks an important step in expanding China’s use of nuclear energy from electricity generation alone toward diversified energy supply. Once completed and put into operation, the Xuwei project is expected to supply more than 35 million tonnes of industrial steam annually, according to CNNC. By combining nuclear power with the energy needs of a large petrochemical industrial base, the project is also expected to provide Chinese experience that can be applied to the low-carbon transformation of energy-intensive industries elsewhere. The article first appeared in the Global Times: https://www.globaltimes.cn/page/202609/1370561.shtml
- September 16, 2026Business
Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer
The phase III TAISHAN-302 trial found that tambotatug pelitecan (Tam-Peli, YL201), a novel anti-B7-H3 antibody-drug conjugate developed by MediLink Therapeutics, significantly improved overall survival, progression-free survival and objective response rate compared with topotecan in patients with relapsed small-cell lung cancer (SCLC). The findings were presented at the IASLC 2026 World Conference on Lung Cancer presidential symposium. Relapsed SCLC remains a highly aggressive disease with limited effective treatment options following first-line immunotherapy and platinum-based chemotherapy. Topotecan has long been the standard second-line treatment, but its survival benefit remains modest and its toxicity profile presents significant clinical burdens. The randomized, open-label study enrolled 451 patients who had relapsed SCLC after first-line therapy. Patients were Patients were randomized 1:1 to receive Tam-Peli (2.0 mg/kg intravenously on day 1 of each 3-week cycle, with a maximum dose of 200 mg) or topotecan (per label) until disease progression or unacceptable toxicity. After a median follow-up of approximately nine months, median overall survival was 13.3 months with Tam-Peli compared with 9.4 months with topotecan, with a hazard ratio (HR) of 0.46 (95% CI: 0.35–0.62; p<0.0001) — a 54% reduction in the risk of death. The survival benefit was consistent across all major subgroups, including patients with brain metastases, liver metastases and those with a chemotherapy-free interval of less than 90 days. Tam-Peli also demonstrated a 71% reduction in the risk of disease progression or death, with median progression-free survival of 7.4 months versus 2.8 months for topotecan (HR 0.29; 95% CI: 0.23–0.37; p<0.0001). The objective response rate was 59.1% with Tam-Peli, compared with 9.7% for topotecan (p<0.0001). The safety profile was manageable and consistent with prior studies. Grade 3 or higher treatment-related adverse events occurred in 46.4% of patients receiving Tam-Peli, versus 74.7% in the topotecan group. There were no treatment-related deaths in the Tam-Peli arm. Interstitial lung disease — a known concern for B7-H3 ADCs — was reported in 4.9% of Tam-Peli patients, with only 0.9% experiencing Grade 3 events and no Grade 4 or 5 cases. A long-elusive target, now clinically validated B7-H3 has drawn intense industry interest for its broad expression across multiple solid tumors, including SCLC, esophageal squamous cell carcinoma, and nasopharyngeal carcinoma, while showing limited presence in normal tissues. Yet the target has proven notoriously difficult to drug. TMALIN® (Tumor Microenvironment Activable LINker-payload) is MediLink's proprietary ADC platform, which has a unique dual-cleavage mechanism releasing payload both extracellularly in the tumor microenvironment and intracellularly in lysosomes. A proprietary tripeptide linker confers high stability in circulation. More than 8,000 patients have been treated with TMALIN®-based ADCs in global trials, generating a robust safety dataset that supports the platform's clinical viability. "In TAISHAN-302, Tam-Peli demonstrates statistically significant and clinically meaningful improvements in overall survival, progression-free survival and response rate compared with topotecan in relapsed SCLC," said Professor Li Zhang from Sun Yat-sen University Cancer Center. "These results support Tam-Peli as a potential new standard of care for second-line SCLC." Global partnerships and regulatory momentum Founded in 2020, MediLink has advanced a novel ADC platform from discovery to positive registrational readout in under six years. In January 2026, the company entered into a global exclusive licensing agreement with Roche for Tam-Peli, with an upfront and near-term milestone payment of $570 million — a record for a single-target ADC out-licensed by a Chinese biotech. Total out-licensing partnerships across MediLink's pipeline have exceeded $10 billion in aggregate value. The drug has received five Breakthrough Therapy Designations from China's CDE for indications including SCLC, nasopharyngeal carcinoma, esophageal squamous cell carcinoma, and pancreatic ductal adenocarcinoma, as well as an FDA Breakthrough Therapy Designation for SCLC. In July 2026, MediLink submitted its first new drug application to China's CDE for nasopharyngeal carcinoma, which was accepted and granted priority review. The second NDA, for relapsed SCLC, was accepted by the CDE in September 2026 — marking the first time any ADC has received an NDA acceptance in SCLC based on Phase III data. A new competitive dynamic Globally, more than 20 B7-H3 ADC candidates are in clinical development, with Chinese biotechs accounting for nearly 80% of the pipeline. Among the five ADCs currently in Phase III stage, four are Chinese-developed. For MediLink, near-term priorities include maturing long-term follow-up data, exploring frontline combinations with PD-1 inhibitors, and advancing regulatory submissions outside China. The Roche partnership is expected to accelerate global development. "SCLC has been a graveyard for drug development for decades," said Tony Xue, CEO of MediLink. "Based on these results, we believe this drug could become the genuinely new standard of care for relapsed SCLC in a generation. And for the field, it finally proves that B7-H3 is a druggable target — that changes the calculus for a whole class of tumors." About MediLink Therapeutics Founded in 2020, MediLink Therapeutics is a biotechnology company focused on innovative conjugated drugs, with its headquarters in Suzhou and R&D centers in Shanghai, Boston, and Singapore. Through proactive and visionary planning, the company has strategically established a full-chain ADC capability. Anchored on the core concept of "tumor microenvironment + lysosomal dual-cleavage mechanism", MediLink has developed proprietary Tumor Microenvironment Activable LINker (TMALIN) platform and other next-generation technology platforms. The safety and efficacy profiles are being consistently validated in multiple clinical studies across the world. To date, MediLink has advanced 15 ADC assets into clinical development, addressing large unmet medical needs. Guided by an entrepreneurial spirit, the company drives integrated innovation across concept, technology, pipeline, clinical studies, global partnerships, and intelligent manufacturing, staying true to its mission of "Innovative Medicines for Global Patients," and striving to bring better treatment options to patients around the world.
- September 15, 2026Others
Trainocate Malaysia Launches AI Training Roadmap 2026, a 7-Level Framework to Close the Enterprise AI Skills Gap
Trainocate Malaysia today announced the launch of its AI Training Roadmap 2026 , a structured, seven-level enterprise upskilling framework designed to take organizations from foundational AI literacy to agentic AI deployment and governance. The program spans over 100 training hours and is customizable across 17 industries, delivered by practitioners with hands-on enterprise AI experience. The launch comes as global AI investment accelerates sharply. According to Gartner, worldwide AI spending is projected to reach $2.59 trillion in 2026, a 47% increase over the previous year. Separately, McKinsey's State of AI research finds that 88% of organizations now use AI in at least one business function, with generative AI adoption climbing to 72% of organizations, up from just 33% in 2024. Yet adoption has outpaced capability. McKinsey's own data shows only about a third of organizations have scaled AI enterprise-wide, and just 37-39% report any measurable profit impact from their AI investments. Trainocate's roadmap is built to address that gap directly, moving employees and leadership alike from basic tool use to production-grade, governed AI deployment. The roadmap's seven levels are structured to serve every stakeholder group, with each program tied to measurable KPIs rather than attendance alone: AI Literacy: Foundation knowledge for all employees AI Productivity: Applied skills for business users AI for Developers: ML & AI engineering for technical teams AI for Automation: Workflow automation for technical and business teams Agentic AI: Autonomous agents for enterprise-scale deployment AI for Leaders: Strategic vision for executives & leaders AI Ethics & Governance: Responsible AI for all stakeholders "Organizations today are not short on AI enthusiasm, they are short on structured capability. The gap between experimenting with AI and running it safely and productively at scale is where most companies get stuck. This roadmap exists to close that gap, level by level, from the front line to the boardroom." said Ruby Kaur, Managing Director of Trainocate Malaysia . Programs are HRDC claimable and available as executive briefings, workshops, or intensive bootcamps, with full customization to an organization's industry, tools, and strategic objectives. Organizations interested in the AI Training Roadmap 2026 can book a complimentary 30-minute strategy consultation with Trainocate Malaysia. About Trainocate Malaysia With over 30 years of experience and a Top 20 IT Training Company for 6 consecutive years , Trainocate is a trusted provider of IT and professional training accredited by HRD Corp, empowering individuals and organizations to build critical digital skills for a rapidly evolving workforce. In Malaysia, Trainocate supports workforce transformation through industry-recognized certifications and practical, outcome-based learning, contributing to the development of future-ready talent.
SELECT NEWS
SUBSCRIBE TO MARKETERSMEDIA NEWS
ALL NEWS
- Midwest Ag Facilities Relieve Grid by Slashing Energy Use with High-Efficiency Grain Bin Fans
- STARCARES Commissions Handmade Gift Sets from Malaysian Autism Charity in Support of Young Artisans
- Studycat identifies emerging bilingual habits among toddlers using fun children Spanish language iOS apps
- Protheragen Launches Specialized Pharmacokinetic Service Platform for Anti-Obesity Therapeutics
- Automation Testing Market Gains Momentum at 14.64% CAGR as AI and DevOps Redefine Software Quality
- TermSquad Launches an Always-On Cloud Computer for AI Coding Agents
- Signature Clinic announces new surgeon appointments as UK team continues to grow
- Voghion Launches Trends, a Content Community Connecting Discovery, Entertainment and Shopping
- Directories supply 41% of AI citations on supplier-selection prompts, new GEO and AEO study finds
- James Champion Honored with USTA President's 35x35 Impact Award
- Rider University Receives Grant for Vocational College Education as Career Planning Expands Beyond Job Placement
- WARCO Hosts House Member Rep. Correa at Southern California Factory to Discuss Growth, Jobs, Taxes
- Global Times: CNNC, IAEA sign HTGR cooperation agreement to share China’s advanced nuclear experience with intl community
- Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer
- Score Academy Online to Showcase Teacher-Supported K-12 Private Education
- CambriLearn Announces 7 October Virtual Open House Introducing CambriOS to UK Families
- Sellervista Launches AI Visibility Tracking and Unified Profit Analytics for Modern E-Commerce Brands
- TrustMinutes Launches Free Trustee Fee, Trust Distribution & Tax Deadline Calculators
ON INSIDER
- Voghion Launches Trends, a Content Community Connecting Discovery, Entertainment and Shopping
- Directories supply 41% of AI citations on supplier-selection prompts, new GEO and AEO study finds
- Rider University Receives Grant for Vocational College Education as Career Planning Expands Beyond Job Placement
- Score Academy Online to Showcase Teacher-Supported K-12 Private Education
- CambriLearn Announces 7 October Virtual Open House Introducing CambriOS to UK Families
- Emerald Coast By Owner Lists Miramar Beach Vacation Rentals By Verified Owners
- Banger Launches Premium Custom Apparel for Startups at Direct Factory Pricing
- NJ Retaining Wall Design & Installation: Landscaping Service Updated
- BKREA Appoints Taylor Bello as Chief Marketing & Operating Officer
- Rider University Emphasizes Career-Focused College Education as Students Seek Clearer Paths From Degree to Work

Google
News
RSS Feed
